These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 34114954)

  • 1. Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study.
    Kim S; Aceti M; Baroutsou V; Bürki N; Caiata-Zufferey M; Cattaneo M; Chappuis PO; Ciorba FM; Graffeo-Galbiati R; Heinzelmann-Schwarz V; Jeong J; Jung MM; Kim SW; Kim J; Lim MC; Ming C; Monnerat C; Park HS; Park SH; Pedrazzani CA; Rabaglio M; Ryu JM; Saccilotto R; Wieser S; Zürrer-Härdi U; Katapodi MC
    JMIR Res Protoc; 2021 Jun; 10(6):e26264. PubMed ID: 34114954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.
    Katapodi MC; Viassolo V; Caiata-Zufferey M; Nikolaidis C; Bührer-Landolt R; Buerki N; Graffeo R; Horváth HC; Kurzeder C; Rabaglio M; Scharfe M; Urech C; Erlanger TE; Probst-Hensch N; Heinimann K; Heinzelmann-Schwarz V; Pagani O; Chappuis PO
    JMIR Res Protoc; 2017 Sep; 6(9):e184. PubMed ID: 28931501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability and Usability of the Family Gene Toolkit for Swiss and Korean Families Harboring
    Baroutsou V; Duong V; Signorini A; Saccilotto R; Ciorba FM; Bürki N; Caiata-Zufferey M; Ryu JM; Kim SW; Lim MC; Monnerat C; Zürrer-Härdi U; Kim J; Heinimann K; Graffeo R; Park JS; Rabaglio M; Chappuis PO; Kim S; Katapodi MC; On Behalf Of The Cascade And K-Cascade Consortia
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort.
    Sarki M; Ming C; Aissaoui S; Bürki N; Caiata-Zufferey M; Erlanger TE; Graffeo-Galbiati R; Heinimann K; Heinzelmann-Schwarz V; Monnerat C; Probst-Hensch N; Rabaglio M; Zürrer-Härdi U; Chappuis PO; Katapodi MC; On Behalf Of The Cascade Consortium
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Openness of Communication in Families With Hereditary Breast and Ovarian Cancer Syndrome: Natural Language Processing Analysis.
    Baroutsou V; Cerqueira Gonzalez Pena R; Schweighoffer R; Caiata-Zufferey M; Kim S; Hesse-Biber S; Ciorba FM; Lauer G; Katapodi M;
    JMIR Form Res; 2023 Jan; 7():e38399. PubMed ID: 36656633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop.
    Nikolaidis C; Ming C; Pedrazzani C; van der Horst T; Kaiser-Grolimund A; Ademi Z; Bührer-Landolt R; Bürki N; Caiata-Zufferey M; Champion V; Chappuis PO; Kohler C; Erlanger TE; Graffeo R; Hampel H; Heinimann K; Heinzelmann-Schwarz V; Kurzeder C; Monnerat C; Northouse LL; Pagani O; Probst-Hensch N; Rabaglio M; Schoenau E; Sijbrands EJG; Taborelli M; Urech C; Viassolo V; Wieser S; Katapodi MC;
    Public Health Genomics; 2018; 21(3-4):121-132. PubMed ID: 30695780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modes of responsibility in disclosing cancer genetic test results to relatives: An analysis of Swiss and Korean narrative data.
    Aceti M; Caiata-Zufferey M; Pedrazzani C; Schweighoffer R; Kim SY; Baroutsou V; Katapodi MC; Kim S;
    Patient Educ Couns; 2024 Jun; 123():108202. PubMed ID: 38395023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Electronic Surviving Cancer Competently Intervention Program-a Psychosocial Digital Health Intervention for English- and Spanish-Speaking Parents of Children With Cancer: Protocol for Randomized Controlled Trial.
    Canter KS; Ritterband L; Freyer DR; Askins MA; Bava L; Loucas C; Arasteh K; You W; Kazak AE
    JMIR Res Protoc; 2023 Jun; 12():e46339. PubMed ID: 37267038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions Facilitating Family Communication of Genetic Testing Results and Cascade Screening in Hereditary Breast/Ovarian Cancer or Lynch Syndrome: A Systematic Review and Meta-Analysis.
    Baroutsou V; Underhill-Blazey ML; Appenzeller-Herzog C; Katapodi MC
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population.
    O'Neill SC; Evans C; Hamilton RJ; Peshkin BN; Isaacs C; Friedman S; Tercyak KP
    Fam Cancer; 2018 Jul; 17(3):351-360. PubMed ID: 29124494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCAShare-Assessment of an animated digital message for intrafamilial communication of pathogenic variant positive test results: A feasibility study.
    Aeilts AM; Carpenter KM; Hovick SR; Byrne L; Shoben AB; Senter L
    J Genet Couns; 2023 Apr; 32(2):475-485. PubMed ID: 36426678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review.
    Afaya A; Kim SW; Park HS; Lim MC; Jung MS; Nam EJ; Park JS; Jeong J; Ryu JM; Kim J; Kim J; Kim M; Jin J; Han J; Kim SY; Park SY; Katapodi MC; Kim S;
    Fam Cancer; 2024 Jun; 23(2):121-132. PubMed ID: 38662264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the Effectiveness of Interactive Webtoons for Premature Birth Prevention: Protocol for a Randomized Controlled Trial.
    Kim SH; De Gagne JC
    JMIR Res Protoc; 2024 May; 13():e58326. PubMed ID: 38748471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study.
    Katapodi MC; Jung M; Schafenacker AM; Milliron KJ; Mendelsohn-Victor KE; Merajver SD; Northouse LL
    JMIR Cancer; 2018 Apr; 4(1):e7. PubMed ID: 29653920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Finding My Way UK Clinical Trial: Adaptation Report and Protocol for a Replication Randomized Controlled Efficacy Trial of a Web-Based Psychological Program to Support Cancer Survivors.
    Hulbert-Williams NJ; Leslie M; Hulbert-Williams L; Koczwara B; Watson EK; Hall PS; Ashley L; Coulson NS; Jackson R; Millington S; ; Beatty L
    JMIR Res Protoc; 2021 Sep; 10(9):e31976. PubMed ID: 34542420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE Cohort.
    Sarki M; Ming C; Aceti M; Fink G; Aissaoui S; Bürki N; Graffeo R; Heinimann K; Caiata Zufferey M; Monnerat C; Rabaglio M; Zürrer-Härdi U; Chappuis PO; Katapodi MC; The Cascade Consortium
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Communication Chain of Genetic Risk: Analyses of Narrative Data Exploring Proband-Provider and Proband-Family Communication in Hereditary Breast and Ovarian Cancer.
    Pedrazzani C; Aceti M; Schweighoffer R; Kaiser-Grolimund A; Bürki N; Chappuis PO; Graffeo R; Monnerat C; Pagani O; Rabaglio M; Katapodi MC; Caiata-Zufferey M
    J Pers Med; 2022 Jul; 12(8):. PubMed ID: 36013197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer.
    Katapodi MC; Munro ML; Pierce PF; Williams RA
    Nurs Res; 2011; 60(6):368-77. PubMed ID: 22048556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results.
    Cragun D; Beckstead J; Farmer M; Hooker G; Dean M; Matloff E; Reid S; Tezak A; Weidner A; Whisenant JG; Pal T
    BMC Cancer; 2021 Oct; 21(1):1099. PubMed ID: 34645413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.